Natural Product: NPC241290

Natural Product IDNPC241290
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
(3Beta,24S)-Stigmasta-5,28-Diene-3,24-Diol
IUPAC Name (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5S)-5-hydroxy-5-propan-2-ylhept-6-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL489548
PubChem CID 14161397
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0002031] Stigmastanes and derivatives

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey OPGVEUGCNGNPSX-BDCPAJACSA-N
Standard InCHI InChI=1S/C29H48O2/c1-7-29(31,19(2)3)17-12-20(4)24-10-11-25-23-9-8-21-18-22(30)13-15-27(21,5)26(23)14-16-28(24,25)6/h7-8,19-20,22-26,30-31H,1,9-18H2,2-6H3/t20-,22+,23+,24-,25+,26+,27+,28-,29+/m1/s1
SMILES C=C[C@@](C(C)C)(CC[C@H]([C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC=C2[C@]1(C)CC[C@@H](C2)O)C)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   428.37 Volume:   488.222
?
Van der Waals volume.
Dense:   0.877 LogP:   6.891
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   4.98
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -6.288
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   6.0 Rigid Bonds:   21.0
TPSA:   40.46
?
Topological Polar Surface Area.
H-Bond Acceptor:   2.0
H-Bond Donor:   2.0 Rings:   4.0
Heavy Atoms:   2.0

MedChem Properties

QED Drug-Likeness Score:   0.451 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.774 Fsp3:   0.862
MCE-18:   74.111
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.829 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.003
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.0
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.577 Promiscuous compounds:   0.086

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.209 MDCK Permeability:   -4.995
Pgp-inhibitor:   0.001 Pgp-substrate:   0.146
PAMPA:   0.019
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.0
20% Bioavailability (F20%):   0.007 30% Bioavailability (F30%):   0.541
50% Bioavailability (F50%):   0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.007 MRP1:   0.016
Plasma Protein Binding (PPB):   84.146% Volume Distribution (VD):   -0.134
Fu: 17.82%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.756
BSEP inhibitor:   0.004

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.001
CYP2C19-inhibitor:   0.012 CYP2C19-substrate:   0.01
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.202
CYP2D6-inhibitor:   0.001 CYP2D6-substrate:   0.049
CYP3A4-inhibitor:   1.0 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.701
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  14.548 Half-life (T1/2):  0.903

ADMET: Toxicity

hERG Blockers:  0.137 hERG Blockers (10um):  0.37
Human Hepatotoxicity (H-HT):  0.662 Drug-induced Liver Injury (DILI):  0.139
AMES Toxicity:  0.166 Rat Oral Acute Toxicity:  0.167
Maximum Recommended Daily Dose:  0.763 Skin Sensitization:  0.974
Carcinogencity:  0.942 Eye Corrosion:  0.23
Eye Irritation:  0.937 Respiratory Toxicity:  0.886
Drug-induced Neurotoxicity:  0.068 Ototoxicity:  0.466
Hematotoxicity:  0.217 Drug-induced Nephrotoxicity:  0.447
Genotoxicity:  0.13 RPMI-8226 Immunitoxicity:  0.046
A549 Cytotoxicity:  0.528 Hek293 Cytotoxicity:  0.703
BCF:   2.373
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.25
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.368
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   5.009
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO22431 Lessonia nigrescens Species Lessoniaceae Eukaryota Tubers n.a. n.a. PMID[11720535]
NPO22674 Caulerpa racemosa Species Caulerpaceae Eukaryota n.a. n.a. n.a. PMID[23548547]
NPO22674 Caulerpa racemosa Species Caulerpaceae Eukaryota n.a. n.a. n.a. PMID[25497963]
NPO22674 Caulerpa racemosa Species Caulerpaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO22431 Lessonia nigrescens Species Lessoniaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO22674 Caulerpa racemosa Species Caulerpaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1210 Individual protein T-cell protein-tyrosine phosphatase Homo sapiens Inhibition < 50.0 % PMID[15270558]
NPT178 Individual protein Protein-tyrosine phosphatase 1B Homo sapiens IC50 = 41700.0 nM PMID[23558238]
NPT205 Individual protein Protein-tyrosine phosphatase 1C Homo sapiens Inhibition < 50.0 % PMID[11277742]
NPT206 Individual protein Protein-tyrosine phosphatase 2C Homo sapiens Inhibition < 50.0 % PMID[211235]
NPT1870 Individual protein Receptor-type tyrosine-protein phosphatase F (LAR) Homo sapiens Inhibition < 50.0 % PMID[24388809]
NPT911 Individual protein Dual specificity phosphatase Cdc25B Homo sapiens Inhibition < 50.0 % PMID[14584959]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT81 Cell line A549 Homo sapiens IC50 > 100000.0 nM DOI[10.1007/s00044-012-0142-7]
NPT88 Organism Mycobacterium tuberculosis Mycobacterium tuberculosis MIC = 1.0 ug.mL-1 PMID[10714491]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 > 100000.0 nM PMID[25497963]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC241290 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC164840
1.0 High Similarity NPC209944
0.8431 Intermediate Similarity NPC484739
0.8077 Intermediate Similarity NPC155986
0.8 Intermediate Similarity NPC162742
0.8 Intermediate Similarity NPC304309
0.8 Intermediate Similarity NPC470228
0.7885 Intermediate Similarity NPC198968
0.7843 Intermediate Similarity NPC22105
0.7843 Intermediate Similarity NPC34019
0.7843 Intermediate Similarity NPC107059
0.7692 Intermediate Similarity NPC136188
0.7692 Intermediate Similarity NPC28657
0.7692 Intermediate Similarity NPC474216
0.7547 Intermediate Similarity NPC230301
0.7547 Intermediate Similarity NPC285893
0.7547 Intermediate Similarity NPC134847
0.7407 Intermediate Similarity NPC264245
0.7273 Intermediate Similarity NPC321381
0.7143 Intermediate Similarity NPC59453
0.7018 Intermediate Similarity NPC603646
0.6897 Remote Similarity NPC473943
0.6852 Remote Similarity NPC600590
0.6842 Remote Similarity NPC472265
0.678 Remote Similarity NPC488870
0.6727 Remote Similarity NPC154330
0.661 Remote Similarity NPC240650
0.661 Remote Similarity NPC155011
0.6607 Remote Similarity NPC113733
0.6552 Remote Similarity NPC318495
0.6545 Remote Similarity NPC221758
0.65 Remote Similarity NPC47761
0.6379 Remote Similarity NPC328714
0.6271 Remote Similarity NPC33913
0.6207 Remote Similarity NPC51014
0.6066 Remote Similarity NPC243985
0.6066 Remote Similarity NPC280710
0.5968 Remote Similarity NPC474164
0.5926 Remote Similarity NPC96319
0.5902 Remote Similarity NPC477522
0.5862 Remote Similarity NPC328313
0.5833 Remote Similarity NPC87604
0.5763 Remote Similarity NPC76879
0.5738 Remote Similarity NPC474634
0.5692 Remote Similarity NPC601043
0.5692 Remote Similarity NPC605412
0.5484 Remote Similarity NPC1272
0.5484 Remote Similarity NPC470614
0.5424 Remote Similarity NPC151519
0.541 Remote Similarity NPC317927
0.5333 Remote Similarity NPC20688
0.5303 Remote Similarity NPC474349
0.5303 Remote Similarity NPC474189
0.5254 Remote Similarity NPC81306
0.5156 Remote Similarity NPC474752
0.5156 Remote Similarity NPC474683
0.5143 Remote Similarity NPC309493
0.5082 Remote Similarity NPC109546
0.5082 Remote Similarity NPC317458
0.5082 Remote Similarity NPC47982
0.5079 Remote Similarity NPC31564
0.5079 Remote Similarity NPC145879

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC241290 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7692 Intermediate Similarity NPD6942 Phase 4
0.7547 Intermediate Similarity NPD7339 Approved
0.6545 Remote Similarity NPD4786 Phase 1
0.5926 Remote Similarity NPD3701 Pre-clinical
0.5424 Remote Similarity NPD3667 Phase 4

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data